Influenza

Researchers to Test IL-6 Blockers After Viruses Found to Wake Dormant Breast Cancer Cells

Data from mouse models alongside human registries reveal that IL-6–driven inflammation during flu and COVID-19 infections awakens dormant breast cancer cells in the lungs, spurring planned clinical trials of IL-6 inhibitors.